Seguimiento de 12 meses de pacientes complejos tratados con stents farmacológicos liberadores de everolimus XIENCE V® en la práctica diaria – resultados del registro brasileño BRAVO
Fabio Conejo, Henrique Barbosa Ribeiro, André Gasparini Spadaro, Roger Renault Godinho, Sandro M. Faig, Camila Gabrilaitis, Mariana Y. Okada, Alexandre Spósito, Carlos Vinícius Espirito-Santo,...
Daniel Chamié, Breno O. Almeida, Fábio Grandic, Evandro M. Filho, J. Ribamar Costa Jr., Ricardo Costa, Rodolfo Staicoa, Dimytri Siqueira, Fausto Feres, Luiz Fernando...
Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...
